|
Pfizer. "Worldwide revenue of Pfizer's Viagra from 2003 to 2019 (in million U.S. dollars)." Chart. Pfizer, Worldwide income of Pfizer's Viagra from 2003 to 2019 (in million U.S. In alternate, the inventor, on this case Pfizer, gets the exclusive rights to market the invention for a restricted interval. The court docket said Pfizer, based in New York, broke that bargain. The Supreme Court of Canada is invalidating Pfizer's patent on the favored erectile-dysfunction drug Viagra for failing to overtly disclose the drug's energetic ingredient, as required by Canadian intellectual property regulation. FDA laboratory evaluation confirmed that Herb Viagra Male Sexual Stimulant comprises sildenafil, the energetic ingredient in Viagra, an FDA-approved prescription drug for erectile dysfunction. The justices stated Pfizer didn't disclose that sildenafil was the energetic compound, while different listed compounds within the patent were not efficient in treating erectile dysfunction. Teva tried to invalidate the patent, arguing partially that the invention for erectile dysfunction was not patent-worthy, and that Pfizer had withheld data from the U.S. That very same year, in one other case, the U.S. It's important to note that noticed associations like this - even on an enormous scale - will not be the identical as proof of a causative effect. |
|